Controlled Release Redefined: The Strategic Use of Excipients in Formulations

Controlled release (CR) formulations play a pivotal role in patient-centric drug design and represent one of the most rapidly evolving drug delivery methods. This upcoming webinar will delve into how functional excipients such as hydroxypropyl methylcellulose (HPMC) are addressing complex CR delivery performance.

Register Free: https://www.pharmtech.com/pt_w/controlled-release-refined

Event Overview:

Controlled release (CR) formulations offer a host of advantages over immediate-release formats when specificity is needed, including improved therapeutic outcomes, reduced dosing frequency, enhanced safety profiles, and minimized adverse effects. These benefits contribute to better patient compliance and treatment adherence. As a result, CR dosage forms are rapidly gaining prominence as one of the most dynamic delivery systems in the pharmaceutical landscape.

This presentation will delve into the intricacies of CR formulations, shedding light on the latest insights. This presentation will also focus on how CR performance is influenced by key excipient physiochemical properties, specifically HPMC viscosity and its ability to form a swollen layer due to body temperature. Moreover, the presentation will explore how strategic HPMC substitution empowers formulators to create CR delivery systems with distinct performance characteristics. Don’t miss this presentation where experts will redefine CR and demonstrate how to unlock the potential of functional excipients in precision drug delivery!

Key Learning Objectives:

• Identify key HPMC properties for CR formulations
• Optimize HPMC properties for enhanced CR performance
• Navigate the nexus: API solubility and HPMC matrix tablet performance

Who Should Attend:

• Formulation and process scientists
• Development scientists
• Drug product regulatory and quality professionals
• Process scale-up engineers

Speakers:

True L. Rogers, PhD
Senior Lead Scientist
IFF Pharma Solutions

True L. Rogers, PhD, is a senior lead scientist and technical fellow at IFF Pharma Solutions. Since returning to R&D from his technical service responsibilities in Germany, Rogers has spent the last 14 years driving innovation and growth. This work includes launching innovation platforms, as well as supporting customers in their customization, development, and problem-solving journeys. He has recently added biologics collaborations to his repertoire, with the development of several projects in this landscape. Rogers is a thoughtful mentor to many scientists across the globe, providing project and personal guidance. He is a licensed pharmacist, earning both his bachelor of science degree in pharmacy and doctor of philosophy degree in pharmaceutics from The University of Texas at Austin.

Adriana Quiroga
Application Development and Innovation Leader, Latin America
IFF Pharma Solutions

Adriana Quiroga is a successful pharmacist with over 20 years of experience in the pharmaceutical industry. Her expertise lies in providing crucial support for the development of oral dosage forms, from initial concepts to production. Quiroga has dedicated nearly 2 decades to working in the field of modified release formulations, with a deeper approach to matrices.

She is an accomplished researcher and has authored and coauthored several posters that were presented at several Latin American congresses, CRS chapters, and conferences for the Association of Pharmaceutical Scientists (AAPS). Prior to her current role, she worked at a distributor, offering technical support to customers. Additionally, she has also served as a professor in a postgraduate course at Universidad de Belgrano and the University of Business and Social Sciences in Buenos Aires, Argentina. Her contributions to the pharmaceutical field continue to make a significant impact.

Register Free: https://www.pharmtech.com/pt_w/controlled-release-refined